Clinical trial

Safety and Efficacy Study of NV-101 in Dental Patients

NCT00154167 · Novalar Pharmaceuticals, Inc., Industry · Completed

Key facts

NCT number NCT00154167
Title Safety and Efficacy Study of NV-101 in Dental Patients
Official title A Double-Blind, Randomized, Placebo-Controlled Study of the Efficacy and Safety of NV-101 in Dental Patients
Lead sponsor Novalar Pharmaceuticals, Inc., Industry
Status Completed
Phase Phase 2
Study type Interventional
Conditions Soft Tissue Anesthesia (Numbness)
Intervention type Drug
Interventions NV-101 (phentolamine mesylate solution)
Enrollment 122
Start date Feb 1, 2003
Completion Jun 1, 2003
First posted Sep 12, 2005
Last update posted Sep 14, 2005
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies